Table 4 Factors associated with satisfaction with activities of daily living

 Age (years)

< 50

Ref

–

–

Ref

–

–

Ref

–

–

50–64

1.67

1.33–2.10

< 0.001

1.55

1.22–1.98

< 0.001

1.52

1.19–1.93

< 0.001

65–74

1.40

1.12–1.76

0.003

1.23

0.97–1.57

0.089

1.15

0.90–1.47

0.255

≥ 75

1.56

1.21–2.02

< 0.001

1.01

0.76–1.34

0.948

1.13

0.85–1.50

0.400

 Sex

Female

1.33

1.09–1.61

0.005

1.03

0.83–1.27

0.792

1.19

0.96–1.47

0.107

 Disease duration (years)

≥ 11

1.59

1.36–1.85

< 0.001

1.25

1.06–1.47

0.009

1.15

0.94–1.39

0.174

 Pain VAS (cm)

> 1.2

6.15

5.18–7.30

< 0.001

2.63

2.13–3.24

< 0.001

–

–

–

 General VAS (cm)

> 0.9

4.19

3.56–4.93

< 0.001

1.35

1.12–1.66

0.003

–

–

–

 EQ5D socre

0.9–1.0

Ref

–

–

Ref

–

–

–

–

–

0.85–0.89

3.96

2.94–5.33

< 0.001

3.24

2.38–4.41

< 0.001

–

–

–

0.75–0.84

5.49

4.41–6.83

< 0.001

3.90

3.09–4.92

< 0.001

–

–

–

0–0.74

18.11

14.37–22.81

< 0.001

9.96

7.7–12.87

< 0.001

–

–

–

TJC

≥ 1

3.70

3.13–4.37

< 0.001

–

–

–

2.02

1.66–2.46

< 0.001

 SJC

≥ 1

3.11

2.63–3.68

< 0.001

–

–

–

1.34

1.10–1.63

0.004

 Log-transformed CRP (mg/dL)

Continuous

1.29

1.22–1.36

< 0.001

–

–

–

1.10

1.03–1.16

0.004

 Physician VAS (cm)

> 0.5

4.30

3.65–5.07

< 0.001

–

–

–

2.41

1.98–2.94

< 0.001

 Steinbrocker stage

3 and 4

2.21

1.89–2.59

< 0.001

–

–

–

1.56

1.26–1.92

< 0.001

 Musculoskeletal surgery

Yes

2.21

1.83–2.66

< 0.001

–

–

–

1.40

1.13–1.72

0.002

 Prednisolone dose (mg)

> 5

2.26

1.60–3.21

< 0.001

–

–

–

1.52

1.05–2.19

0.027

 Methotrexate use

Yes

0.87

0.74–1.03

0.116

–

–

–

0.91

0.76–1.09

0.303

 b/tsDMARDs use

Yes

0.98

0.83–1.15

0.773

–

–

–

0.78

0.65–0.94

0.008